| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |